Ação do composto do complexo nitrosil-rutênio cis-[Ru(bpy)2IMn(NO)]+3, na musculatura lisa cavernosa de humanos

• Ano de defesa: 2013
• Autor(a) principal: Leitão Júnior, Alexandre Sabóia
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Palavras-chave em Português: Óxido Nítrico; Compostos de Rutênio
• Link de acesso: http://www.repositorio.ufc.br/handle/riufc/8747

Deficiency of nitric oxide (NO) has been implicated as one of the main mechanisms of Endothelial dysfunction and erectile dysfunction. The search for new medications must be important to lessen the burden of this disease. The study evaluated the relaxation, in vitro, induced by a new drug of the Nitrosyl-Ruthenium complex (RUT-BPY-IMI) into strips of corpora cavernosa, taken from non-living human organ donor for transplantation. The strips were immersed in tissue baths in Krebs solution (pH7 .4, 37° C). They were contracted in 80 mm K + solution, and later again with Phenylephrine (PHE 10 μm) and concentration-response curves (10-12 to 10-4μM) were obtained. Initially the drug was compared with the vehicle (DMSO) and then with substances which have already been used in other studies. These drugs showed very good relaxing effects (SNP, BAY 41-2272 and Vardenafil). To clarify the mechanism by which this drug promotes relaxation, the following experiments were carried out: evaluation of relaxation achieved with the contraction with 80 mm K +, effect of an inhibitor of nitric oxide syntase (NOS), L-NAME (100 μm); addition of ODQ (30 μm), an inhibitor of the soluble GuanylateCyclase; a remover of the extracellular NO, bovine Hemoglobin (30 μm); Glibenclamide (10 μm), a potassium ion channel blocker ATP-dependent (KATP). The tissues exposed to the RUT-BPY-IMI, SNP and DMSO were frozen in liquid nitrogen to measure the amount of GMPc.The substance caused an EMAX relaxation in smooth muscle of the corpus cavernosum (EMAX = 112.92% ± 10.03% and pEC50 = 4.991 ± 0.1916), 70% more than the vehicle. Comparing RUT-BPY-IMI with the SNP, the drug studied showed as efficient as the SNP, there were no difference between both EMAX (p = 0,3437),. Compared with the BAY 41-2272, there was no statistical difference in any of the parameters studied (pEC50 and EMAX).. The EMAX achieved in concentration-response curve with 80 mm K + was about 20% lower than the curve with PHE (10 μm) (p = 0.0208). There was no inhibition of the relaxing effect of drug with L-NAME (p 0.05 >), or deviation from the curve to the right. The addition of ODQ (30 μm) to the bath, decreased 50% of the EMAX of the substance (p<0,05). The addition of bovine hemoglobin (30 μm) did not alter the capacity maximum relaxing substance (p<0,05). There was no inhibition or blockade of the maximum effect of the drug with Glibenclamide (10 μm) (p 0.05 >). The RUT-BPY-IMI tissue concentration of cGMP produced was 74% over the vehicle, and less than the SNP (p<0,05).RUT-BPY-IMI is a NO-donor, it produces a powerful relaxation of the smooth muscle of the corpus cavernosum. Probably, the substance does not induce NOS, acts by activating the soluble guanylateCyclase, which produces cGMP, releasing the intracellular NO. It seems that it does not activate potassium channels, and not act throw KATP.